| Sep 9 |
Tonix Pharmaceuticals soars after positive data on its potential mpox vaccine
|
| Sep 9 |
TNXP: Mpox Declared a Public Health Emergency of International Concern by World Health Organization…
|
| Sep 9 |
Tonix Pharmaceuticals Presented Data on the Potential Mpox Vaccine TNX-801 in “Using Synthetic Biology to Battle Mpox” Talk at Immunology Symposium at the University of Alberta
|
| Sep 9 |
Why Summit Therapeutics Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
|
| Sep 6 |
Tonix Pharmaceuticals Launches National Awareness Campaign on the Impact of Gastroparesis or Stomach Paralysis on the Absorption of Oral Migraine Medications at PAINWeek
|
| Sep 5 |
Singapore announces quarantine measures for close contacts of mpox infected patients
|
| Sep 4 |
As Research into Pain Accelerates, a Newly Recognized Type of Pain Comes to the Forefront - Tonix Targets it with FDA-Fast Track-Designated TNX-102 SL
|
| Aug 31 |
UNICEF issues emergency tender to secure mpox vaccines
|
| Aug 29 |
Tonix Pharmaceuticals Presented Data from Two Posters on TNX-102 SL for Reduction of Acute Stress Reaction and Prevention of PTSD and One Poster for Wound Healing at the 2024 Military Health System Research Symposium (MHSRS)
|
| Aug 28 |
Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the 2024 Military Health System Research Symposium (MHSRS)
|
